Broker-Dealers on SEC Form D for MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED

Search by Recipient Name or Primary Issuer:

Displaying 811-820 out of 2,341 results

Recipient	CRD	Primary Issuer	CIK	Filing Date	Form Type	Total Offering Amount	Total Amount Sold
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	AQR Tax Advantaged Global Equity Market Neutral Fund, L.P.	1616851	02/09/2023	D/A	Indefinite	$389,456,414
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	AQR Tax Advantaged Global Equity Market Neutral Fund, L.P.	1616851	05/12/2022	D/A	Indefinite	$388,556,414
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	Paulson Advantage Access LLC	1340702	03/12/2012	D/A	Indefinite	$387,418,242
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	AQR Tax Advantaged Global Equity Market Neutral Fund, L.P.	1616851	02/10/2022	D/A	Indefinite	$385,556,414
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	AQR Tax Advantaged Global Equity Market Neutral Fund, L.P.	1616851	11/12/2021	D/A	Indefinite	$384,606,414
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	Blackstone Life Sciences V Access Fund, L.P.	1817675	09/18/2020	D/A	$383,868,991	$383,868,991
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	AQR Tax Advantaged Global Equity Market Neutral Fund, L.P.	1616851	09/09/2021	D/A	Indefinite	$383,706,414
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	AQR Tax Advantaged Global Equity Market Neutral Fund, L.P.	1616851	08/12/2021	D/A	Indefinite	$383,206,414
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	SCP Endowment Fund, L.P.	1424897	02/27/2015	D/A	Indefinite	$381,832,493
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691	MESIROW ABSOLUTE RETURN FUND, LTD.	1161687	07/13/2018	D/A	Indefinite	$379,513,335